In the present work, we demonstrated that m6A-modified circUHRF2 by METTL3 contributed to CRC stemness and metastasis by recruiting IGF2BP1 to suppress the loss of DDX27 protein, highlighting the potential of circUHRF2 intervention as a therapeutic strategy for CRC. Here, METTL3 is linked to colorectal carcinoma.